亚临床甲状腺功能减退对非酒精性脂肪性肝病发生发展的影响：一项前瞻性病例对照研究。 - Suppr

Suppr

超能文献

Impact of subclinical hypothyroidism on the development of non-alcoholic fatty liver disease: a prospective case-control study.

作者信息

Xu Lei, Ma Han, Miao Min, Li Youming

出版信息

J Hepatol. 2012 Nov;57(5):1153-4. doi: 10.1016/j.jhep.2012.05.025. Epub 2012 Aug 30.

DOI:10.1016/j.jhep.2012.05.025

PMID:22940010

Abstract

摘要

相似文献

Impact of subclinical hypothyroidism on the development of non-alcoholic fatty liver disease: a prospective case-control study.亚临床甲状腺功能减退对非酒精性脂肪性肝病发生发展的影响：一项前瞻性病例对照研究。

J Hepatol. 2012 Nov;57(5):1153-4. doi: 10.1016/j.jhep.2012.05.025. Epub 2012 Aug 30.

Non-alcoholic fatty liver disease across the spectrum of hypothyroidism.非酒精性脂肪性肝病与甲状腺功能减退症的关系。

J Hepatol. 2012 Jul;57(1):150-6. doi: 10.1016/j.jhep.2012.02.027. Epub 2012 Mar 14.

Diagnosis of non-alcoholic fatty liver disease in obese children.肥胖儿童非酒精性脂肪性肝病的诊断

J Pediatr Endocrinol Metab. 2012;25(5-6):613. doi: 10.1515/jpem-2012-0072.

Population-based screening programs for nonalcoholic fatty liver disease in youth and clues to prevention.

J Clin Endocrinol Metab. 2014 Mar;99(3):774-6. doi: 10.1210/jc.2014-1290.

Fatty liver largely explains associations of subclinical hypothyroidism with insulin resistance, metabolic syndrome, and subclinical coronary atherosclerosis.脂肪肝在很大程度上解释了亚临床甲状腺功能减退症与胰岛素抵抗、代谢综合征和亚临床冠状动脉粥样硬化之间的关联。

Eur J Endocrinol. 2014 Sep;171(3):319-25. doi: 10.1530/EJE-14-0150.

Non-alcoholic fatty liver and cardiovascular disease: an emerging relationship.

Hellenic J Cardiol. 2007 Jan-Feb;48(1):37-41.

Hormone replacement therapy in menopausal women: risk factor or protection to nonalcoholic fatty liver disease?

Ann Hepatol. 2012 Jan-Feb;11(1):147-9.

Presence and association of sub clinical hypothyroidism in subjects with metabolic syndrome.代谢综合征患者中亚临床甲状腺功能减退症的存在及其相关性。

Diabetes Metab Syndr. 2011 Oct-Dec;5(4):183-7. doi: 10.1016/j.dsx.2010.12.006. Epub 2011 Jan 19.

Low 25-hydroxyvitamin D3 serum levels and non-alcoholic fatty liver disease.

Minerva Med. 2014 Apr;105(2):175.

Impact of fatty liver disease and metabolic syndrome on incident type 2 diabetes; a population based cohort study.脂肪肝疾病和代谢综合征对2型糖尿病发病的影响；一项基于人群的队列研究。

Endocr J. 2017 Nov 29;64(11):1105-1114. doi: 10.1507/endocrj.EJ17-0245. Epub 2017 Sep 2.

引用本文的文献

Hypothyroidism/subclinical hypothyroidism and metabolic dysfunction-associated steatotic liver disease: advances in mechanism and treatment.甲状腺功能减退/亚临床甲状腺功能减退与代谢功能障碍相关脂肪性肝病：机制与治疗进展

Lipids Health Dis. 2025 Feb 27;24(1):75. doi: 10.1186/s12944-025-02474-0.

Revisiting the relationship between thyroid function and metabolic dysfunction-associated steatotic liver disease in the era of resmetirom.在resmetirom时代重新审视甲状腺功能与代谢功能障碍相关脂肪性肝病之间的关系。

J Gastroenterol. 2025 Mar;60(3):389-391. doi: 10.1007/s00535-025-02214-2. Epub 2025 Jan 23.

Use of transient elastography for hepatic steatosis and fibrosis evaluation in patients with subclinical hypothyroidism.应用瞬时弹性成像技术评估亚临床甲状腺功能减退症患者的肝脂肪变和纤维化。

Arch Endocrinol Metab. 2024 Aug 9;68:e230477. doi: 10.20945/2359-4292-2023-0477. eCollection 2024.

Actions of thyroid hormones and thyromimetics on the liver.甲状腺激素和拟甲状腺药物对肝脏的作用。

Nat Rev Gastroenterol Hepatol. 2025 Jan;22(1):9-22. doi: 10.1038/s41575-024-00991-4. Epub 2024 Oct 17.

Association between thyroid function and nonalcoholic fatty liver disease: a dose-response meta-analysis.甲状腺功能与非酒精性脂肪性肝病的关系：一项剂量-反应荟萃分析。

Front Endocrinol (Lausanne). 2024 Jun 25;15:1399517. doi: 10.3389/fendo.2024.1399517. eCollection 2024.

Pharmacotherapies of NAFLD: updated opportunities based on metabolic intervention.非酒精性脂肪性肝病的药物治疗：基于代谢干预的新机遇

Nutr Metab (Lond). 2023 Jul 6;20(1):30. doi: 10.1186/s12986-023-00748-x.

Resmetirom: An Orally Administered, Smallmolecule, Liver-directed, β-selective THR Agonist for the Treatment of Non-alcoholic Fatty Liver Disease and Non-alcoholic Steatohepatitis.瑞美替隆：一种口服的小分子、肝脏靶向、β 选择性甲状腺激素受体激动剂，用于治疗非酒精性脂肪性肝病和非酒精性脂肪性肝炎。

touchREV Endocrinol. 2023 May;19(1):60-70. doi: 10.17925/EE.2023.19.1.60. Epub 2023 May 1.

Association of Subclinical Hypothyroidism with Nonalcoholic Fatty Liver Disease in Patients with Type 2 Diabetes Mellitus: A Cross-Sectional Study.2型糖尿病患者亚临床甲状腺功能减退与非酒精性脂肪性肝病的关联：一项横断面研究

Adv Biomed Res. 2022 Dec 26;11:124. doi: 10.4103/abr.abr_15_21. eCollection 2022.

Hypothyroidism-Associated Dyslipidemia: Potential Molecular Mechanisms Leading to NAFLD.甲状腺功能减退症相关血脂异常：导致非酒精性脂肪性肝病的潜在分子机制。

Int J Mol Sci. 2021 Nov 26;22(23):12797. doi: 10.3390/ijms222312797.

Primary Versus Secondary NAFLD: Perspective on Advanced Fibrosis.原发性与继发性非酒精性脂肪性肝病：关于晚期肝纤维化的观点

J Clin Exp Hepatol. 2021 Sep-Oct;11(5):557-564. doi: 10.1016/j.jceh.2020.12.009. Epub 2020 Dec 31.

文献AI研究员

20分钟写一篇综述，助力文献阅读效率提升50倍。

立即体验

用中文搜PubMed

大模型驱动的PubMed中文搜索引擎

马上搜索

文档翻译

学术文献翻译模型，支持多种主流文档格式。

立即体验